Table 1Effectiveness of Medications To Prevent Fracture Risk

The table below lists whether or not the following medications reduce the risk of the listed fracture types for postmenopausal women with osteoporosis.

MedicationVertebralNonvertebralHipWrist
BisphosphonatesAlendronateImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu3.jpg
RisedronateImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu3.jpg*
Zoledronic acidImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu1.jpgNot specified
IbandronateImage clinbone2fu1.jpgNot specifiedNot specifiedNot specified
DenosumabImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu1.jpgNot specified
TeriparatideImage clinbone2fu1.jpgImage clinbone2fu2.jpgNot specifiedNot specified
RaloxifeneImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu1.jpgImage clinbone2fu1.jpg

☑ = reduced fracture risk; ☒ = did NOT reduce fracture risk

*

Risedronate-mediated reduction in wrist fracture did not reach the conventional level of statistical significance.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.